Chief Executive Officer
Mon, Aug 15, 2022
Aug 15
10,686 shares @ $0.00
Decreased holdings by -18.70%
Net across this filing: +0.50% (+6,683 shares)
36th largest trade (out of 185)
Option Exercise
Trade made by an officer
Sale tied to a same-time option exercise
Net holdings across this filing: +0.5% (+6,683 shares)
40% win rate · -7.5% median edge vs SPY (5 trades, 90-day · small sample)
Price 69% above 200-day moving average
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
DAWNDay One Biopharmaceuticals, Inc.
HealthcareBiotechnology